British pharmaceutical giant GlaxoSmithKline (GSK) announced Monday that it has started a new rheumatoid arthritis study which uses Apple's ResearchKit platform that lets medical researchers gather robust and meaningful data from iPhone users. The drug maker will be using ResearchKit in its new GSK PARADE iPhone app.
GlaxoSmithKline starts rheumatoid arthritis study using Apple’s ResearchKit